Kanwarjit Singh

Understanding the Impact of Male Circumcision Interventions on the Spread of HIV in Southern Africa

Laith J. Abu-Raddad, Richard G. White, Kanwarjit Singh, 2008, PLoS ONE.

Comparative efficacy of cemiplimab versus other systemic treatments for advanced cutaneous squamous cell carcinoma.

C. Schmults, E. Stockfleth, D. Ayers, 2020, Future oncology.

Treatment patterns and costs in cutaneous squamous cell carcinoma (CSCC) patients with nodal dissection, chemotherapy, and/or radiation therapy.

C. Schmults, Q. Harshaw, M. Fury, 2018 .

Long-Term (≥4 Year and ≥5 Year) Overall Survival (OS) By 12- and 24-Month Event-Free Survival (EFS): An Updated Analysis of ZUMA-1, the Pivotal Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Refractory Large B-Cell Lymphoma (LBCL)

I. Flinn, D. Miklos, C. Jacobson, 2021, Blood.

The potential global market size and public health value of an HIV-1 vaccine in a complex global market.

N. Russell, J. Esparza, C. Marzetta, 2010, Vaccine.

Male circumcision for the prevention of HSV-2 and HPV infections.

R. Ridzon, Kanwarjit Singh, 2009, The New England journal of medicine.

Oral healthcare for elderly: identifying the needs and feasible strategies for service provision.

P. Goel, M. Verma, Arundeep Kaur, 2006, Indian journal of dental research : official publication of Indian Society for Dental Research.

Streptococcal glossal myonecrosis: is conservative treatment possible?

R. Chaudhry, Kanwarjit Singh, Ramanthan Saranga Bharathi, 2009, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma

I. Flinn, D. Miklos, C. Jacobson, 2023, Blood.